Galderma
| Galderma
|
|
|---|---|
 |
|
| legal form | Corporation |
| founding | 1981 |
| Seat | Lausanne , Switzerland |
| management |
Humberto C. Antunes ( CEO ) |
| Number of employees | > 6000 (2017) |
| sales | 1.2 billion euros (2010) |
| Website | www.galderma.com |
The Galderma SA is a Swiss pharmaceutical company based in Lausanne .
Companies
The product portfolio as well as research and development are geared towards the field of dermatology . The product range includes drugs for the treatment of diseases of the skin , hair and nails .
Galderma has research and development centers in Sophia Antipolis (France), Princeton (New Jersey) and Tokyo . The production facilities are located in Alby-sur-Chéran (France), Montreal (Canada) and Hortolândia (Brazil).
The company has 31 offices on five continents. The German branch operates as Galderma Laboratorium GmbH and is based in Düsseldorf .
Company history
Galderma was founded in 1981 as a joint venture between Nestlé and L'Oréal . Seven years later, the joint venture took over the dermatological business of Alcon , which was taken over by Nestlé in 1977. In 1995 Galderma brought the acne therapeutic agent Differin (active ingredient: adapalen ), the first self-developed drug onto the market. Basotherm GmbH, a subsidiary of Boehringer Ingelheim , was taken over in 1997. With Silkis (active ingredient: calcitriol ), a remedy for psoriasis was brought onto the market in 2000 . In 2001, Galderma acquired an exclusive license for the production and distribution of Metvix (active ingredient: methyl 5-amino-4-oxopentanoate ) from the Norwegian company Photocure . In 2003 Metvix began selling . In 2008 CollaGenex Pharmaceuticals was taken over with the brand Oracea , an agent against rosacea (active ingredient: doxycycline ). The anti-wrinkle agent Azzalure (active ingredient: botulinum toxin ) was launched on the European market in 2009. In 2011, the company Q-Med based in Uppsala (Sweden) was taken over. Q-Med is active in the field of breast enlargement using injections of hyaluronic acid . In 2014 Nestlé took over the 50% stake in L'Oréal, and Galderma has since been part of the new Nestlé Skin Health division. In 2019, Nestlé sold Galderma to a consortium led by the financial investor EQT and the Abu Dhabi Investment Authority (ADIA)
Individual evidence
- ↑ galderma.de: Galderma worldwide. Retrieved July 21, 2017.
- ↑ galderma.de: Imprint data according to §5 Telemediengesetz. Retrieved July 21, 2017.
- ↑ galderma.com: Our History. Retrieved July 21, 2017.
- ^ J. Wittwer: Nestlé is attracted to beauty. In: Welt-Online from July 12, 2011.
- ↑ aktiencheck.de: Nestlé share: Acquisition of Galderma completed - Vontobel continues to recommend buying! July 9, 2014.
- ↑ Finance and Economy: Sale of Nestlé Skin Health is complete. Retrieved April 25, 2020 .